Lise Roca

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial

François Quénet, Dominique Élias, Lise Roca et al. · The Lancet Oncology · 2021 · 789 citations · Full text

Medicine, Oncology, Surgery +12

A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7.

François Quénet, Dominique Élias, Lise Roca et al. · Journal of Clinical Oncology · 2018 · 326 citations

Medicine, Oncology, Surgery +13

Results of Two Bi-Institutional Prospective Studies Using Intraperitoneal Oxaliplatin With or Without Irinotecan During HIPEC After Cytoreductive Surgery for Colorectal Carcinomatosis

F. Quénet, Diane Goèré, Sanket Mehta et al. · Annals of Surgery · 2011 · 176 citations

Medicine, Oncology, Surgery +15

Characterization of an adaptive immune response in microsatellite-instable colorectal cancer

Florence Boissière‐Michot, Gwendal Lazennec, Hélène Frugier et al. · OncoImmunology · 2014 · 90 citations · Full text

Life Sciences, Immunology, Oncology +17

Correlation of HER2, FCGR2A, and FCGR3A gene polymorphisms with trastuzumab related cardiac toxicity and efficacy in a subgroup of patients from UNICANCER-PACS04 trial

Lise Roca, Véronique Dièras, Henri Roché et al. · Breast Cancer Research and Treatment · 2013 · 69 citations

Medicine, Cardiology, Genetics +15